CN104001057B - For treating the heart schizoid medicine of kidney disorder type and preparation method thereof - Google Patents
For treating the heart schizoid medicine of kidney disorder type and preparation method thereof Download PDFInfo
- Publication number
- CN104001057B CN104001057B CN201410258697.2A CN201410258697A CN104001057B CN 104001057 B CN104001057 B CN 104001057B CN 201410258697 A CN201410258697 A CN 201410258697A CN 104001057 B CN104001057 B CN 104001057B
- Authority
- CN
- China
- Prior art keywords
- weight portion
- radix
- rhizoma
- medicine
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 105
- 210000002216 heart Anatomy 0.000 title claims abstract description 67
- 208000017169 kidney disease Diseases 0.000 title claims abstract description 28
- 201000006370 kidney failure Diseases 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- 238000011282 treatment Methods 0.000 claims abstract description 89
- 239000000463 material Substances 0.000 claims abstract description 60
- 241000628997 Flos Species 0.000 claims abstract description 40
- 210000000582 semen Anatomy 0.000 claims abstract description 38
- 241000237636 Pheretima Species 0.000 claims abstract description 22
- 239000011021 lapis lazuli Substances 0.000 claims abstract description 20
- 229920002472 Starch Polymers 0.000 claims abstract description 19
- 241000255791 Bombyx Species 0.000 claims abstract description 18
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 claims abstract description 18
- 235000001892 vitamin D2 Nutrition 0.000 claims abstract description 18
- 239000011653 vitamin D2 Substances 0.000 claims abstract description 18
- 239000008517 radix Trichosanthis Substances 0.000 claims abstract description 16
- 235000012239 silicon dioxide Nutrition 0.000 claims abstract description 16
- 241001116389 Aloe Species 0.000 claims abstract description 15
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 15
- 235000019890 Amylum Nutrition 0.000 claims abstract description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 136
- 239000000243 solution Substances 0.000 claims description 43
- 239000013521 mastic Substances 0.000 claims description 40
- 239000000284 extract Substances 0.000 claims description 33
- 239000000843 powder Substances 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 239000000203 mixture Substances 0.000 claims description 21
- 238000010992 reflux Methods 0.000 claims description 20
- 239000007788 liquid Substances 0.000 claims description 17
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 16
- 239000006071 cream Substances 0.000 claims description 16
- 210000001113 umbilicus Anatomy 0.000 claims description 15
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 14
- 238000010438 heat treatment Methods 0.000 claims description 14
- 238000011084 recovery Methods 0.000 claims description 14
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 12
- 235000021355 Stearic acid Nutrition 0.000 claims description 12
- 239000012153 distilled water Substances 0.000 claims description 12
- 239000002552 dosage form Substances 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 12
- 239000008187 granular material Substances 0.000 claims description 12
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 12
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 12
- 230000002829 reductive effect Effects 0.000 claims description 12
- 239000008117 stearic acid Substances 0.000 claims description 12
- 230000008569 process Effects 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 9
- 229930006000 Sucrose Natural products 0.000 claims description 8
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 8
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 8
- 239000006187 pill Substances 0.000 claims description 8
- 239000000047 product Substances 0.000 claims description 8
- 239000011265 semifinished product Substances 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 238000004659 sterilization and disinfection Methods 0.000 claims description 8
- 239000000758 substrate Substances 0.000 claims description 8
- 229960004793 sucrose Drugs 0.000 claims description 8
- 238000001816 cooling Methods 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 5
- 239000008107 starch Substances 0.000 claims description 5
- 235000019698 starch Nutrition 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 4
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 4
- 238000003113 dilution method Methods 0.000 claims description 4
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 claims description 4
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims description 4
- 239000004744 fabric Substances 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 239000008101 lactose Substances 0.000 claims description 4
- 235000019359 magnesium stearate Nutrition 0.000 claims description 4
- 239000012567 medical material Substances 0.000 claims description 4
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 4
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 4
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 4
- GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 claims description 4
- 238000001556 precipitation Methods 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 43
- 210000003734 kidney Anatomy 0.000 abstract description 39
- 201000000980 schizophrenia Diseases 0.000 abstract description 17
- 230000008901 benefit Effects 0.000 abstract description 11
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 abstract description 4
- 231100000957 no side effect Toxicity 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 210000004369 blood Anatomy 0.000 description 68
- 239000008280 blood Substances 0.000 description 68
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 44
- 210000004185 liver Anatomy 0.000 description 41
- 201000010099 disease Diseases 0.000 description 40
- 210000002784 stomach Anatomy 0.000 description 38
- 235000009508 confectionery Nutrition 0.000 description 34
- 208000002193 Pain Diseases 0.000 description 32
- 230000036407 pain Effects 0.000 description 32
- 206010062717 Increased upper airway secretion Diseases 0.000 description 31
- 208000026435 phlegm Diseases 0.000 description 31
- 210000004072 lung Anatomy 0.000 description 27
- 210000000952 spleen Anatomy 0.000 description 23
- 230000007812 deficiency Effects 0.000 description 22
- 230000001737 promoting effect Effects 0.000 description 22
- 208000024891 symptom Diseases 0.000 description 22
- 230000001717 pathogenic effect Effects 0.000 description 21
- 206010010904 Convulsion Diseases 0.000 description 19
- 230000006870 function Effects 0.000 description 19
- 230000036461 convulsion Effects 0.000 description 18
- 238000012360 testing method Methods 0.000 description 18
- 230000035922 thirst Effects 0.000 description 18
- 206010011224 Cough Diseases 0.000 description 17
- 241001465754 Metazoa Species 0.000 description 17
- 206010047700 Vomiting Diseases 0.000 description 16
- 239000003172 expectorant agent Substances 0.000 description 16
- 230000003419 expectorant effect Effects 0.000 description 16
- 230000008673 vomiting Effects 0.000 description 15
- 208000001848 dysentery Diseases 0.000 description 13
- 231100000614 poison Toxicity 0.000 description 13
- 208000006820 Arthralgia Diseases 0.000 description 12
- 230000001276 controlling effect Effects 0.000 description 12
- 210000003205 muscle Anatomy 0.000 description 12
- 230000008961 swelling Effects 0.000 description 12
- 206010010774 Constipation Diseases 0.000 description 11
- 206010003549 asthenia Diseases 0.000 description 11
- 210000000988 bone and bone Anatomy 0.000 description 11
- 239000002398 materia medica Substances 0.000 description 11
- 206010012735 Diarrhoea Diseases 0.000 description 10
- 206010033557 Palpitations Diseases 0.000 description 10
- 206010037660 Pyrexia Diseases 0.000 description 10
- 230000017531 blood circulation Effects 0.000 description 10
- 206010015037 epilepsy Diseases 0.000 description 10
- 244000052769 pathogen Species 0.000 description 10
- 230000001225 therapeutic effect Effects 0.000 description 10
- 206010007247 Carbuncle Diseases 0.000 description 9
- 241000699670 Mus sp. Species 0.000 description 9
- 208000001431 Psychomotor Agitation Diseases 0.000 description 9
- 206010038743 Restlessness Diseases 0.000 description 9
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 9
- 210000001124 body fluid Anatomy 0.000 description 9
- 239000010839 body fluid Substances 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- 230000004438 eyesight Effects 0.000 description 9
- 206010022437 insomnia Diseases 0.000 description 9
- 201000007227 lymph node tuberculosis Diseases 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- 210000005036 nerve Anatomy 0.000 description 9
- 238000010791 quenching Methods 0.000 description 9
- 206010000087 Abdominal pain upper Diseases 0.000 description 8
- 208000032843 Hemorrhage Diseases 0.000 description 8
- 208000028017 Psychotic disease Diseases 0.000 description 8
- 230000001149 cognitive effect Effects 0.000 description 8
- 230000007547 defect Effects 0.000 description 8
- 230000003203 everyday effect Effects 0.000 description 8
- 239000003440 toxic substance Substances 0.000 description 8
- 238000010792 warming Methods 0.000 description 8
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 7
- 208000005392 Spasm Diseases 0.000 description 7
- 238000010171 animal model Methods 0.000 description 7
- 230000006399 behavior Effects 0.000 description 7
- 238000003304 gavage Methods 0.000 description 7
- 230000023597 hemostasis Effects 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 231100000252 nontoxic Toxicity 0.000 description 7
- 230000003000 nontoxic effect Effects 0.000 description 7
- 239000002574 poison Substances 0.000 description 7
- 230000001105 regulatory effect Effects 0.000 description 7
- 208000011580 syndromic disease Diseases 0.000 description 7
- 235000019640 taste Nutrition 0.000 description 7
- 201000004624 Dermatitis Diseases 0.000 description 6
- 208000004547 Hallucinations Diseases 0.000 description 6
- 206010019233 Headaches Diseases 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 6
- 208000003251 Pruritus Diseases 0.000 description 6
- 241000191967 Staphylococcus aureus Species 0.000 description 6
- 208000033809 Suppuration Diseases 0.000 description 6
- 210000001015 abdomen Anatomy 0.000 description 6
- 230000001154 acute effect Effects 0.000 description 6
- 230000001186 cumulative effect Effects 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 230000008451 emotion Effects 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 231100000869 headache Toxicity 0.000 description 6
- 241000411851 herbal medicine Species 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 230000000968 intestinal effect Effects 0.000 description 6
- 210000000936 intestine Anatomy 0.000 description 6
- 230000000698 schizophrenic effect Effects 0.000 description 6
- 230000007958 sleep Effects 0.000 description 6
- 208000004371 toothache Diseases 0.000 description 6
- 210000001835 viscera Anatomy 0.000 description 6
- 208000004998 Abdominal Pain Diseases 0.000 description 5
- 206010010071 Coma Diseases 0.000 description 5
- 206010012239 Delusion Diseases 0.000 description 5
- 208000008454 Hyperhidrosis Diseases 0.000 description 5
- 206010026749 Mania Diseases 0.000 description 5
- 206010068319 Oropharyngeal pain Diseases 0.000 description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 206010043458 Thirst Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 230000036528 appetite Effects 0.000 description 5
- 235000019789 appetite Nutrition 0.000 description 5
- 208000006673 asthma Diseases 0.000 description 5
- 210000000038 chest Anatomy 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 230000002950 deficient Effects 0.000 description 5
- 231100000868 delusion Toxicity 0.000 description 5
- 208000001780 epistaxis Diseases 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 210000000232 gallbladder Anatomy 0.000 description 5
- 210000003128 head Anatomy 0.000 description 5
- 208000021760 high fever Diseases 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 230000008506 pathogenesis Effects 0.000 description 5
- 230000021317 sensory perception Effects 0.000 description 5
- 238000010025 steaming Methods 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 239000003053 toxin Substances 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- 235000014101 wine Nutrition 0.000 description 5
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 208000007101 Muscle Cramp Diseases 0.000 description 4
- 206010036790 Productive cough Diseases 0.000 description 4
- 206010043376 Tetanus Diseases 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 208000031971 Yin Deficiency Diseases 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 208000002399 aphthous stomatitis Diseases 0.000 description 4
- 230000000740 bleeding effect Effects 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 230000001914 calming effect Effects 0.000 description 4
- 230000003750 conditioning effect Effects 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 208000014617 hemorrhoid Diseases 0.000 description 4
- 201000001881 impotence Diseases 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- 201000004792 malaria Diseases 0.000 description 4
- 235000013372 meat Nutrition 0.000 description 4
- 230000001617 migratory effect Effects 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 244000045947 parasite Species 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 235000014347 soups Nutrition 0.000 description 4
- 210000003802 sputum Anatomy 0.000 description 4
- 208000024794 sputum Diseases 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000035900 sweating Effects 0.000 description 4
- 238000010998 test method Methods 0.000 description 4
- 231100000765 toxin Toxicity 0.000 description 4
- 206010000077 Abdominal mass Diseases 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010011878 Deafness Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 206010013954 Dysphoria Diseases 0.000 description 3
- 208000004232 Enteritis Diseases 0.000 description 3
- 201000000297 Erysipelas Diseases 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 208000015817 Infant Nutrition disease Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 208000019255 Menstrual disease Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 206010034702 Persecutory delusion Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 208000032023 Signs and Symptoms Diseases 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- 206010072170 Skin wound Diseases 0.000 description 3
- 206010042674 Swelling Diseases 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 230000003935 attention Effects 0.000 description 3
- 235000019658 bitter taste Nutrition 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 230000003177 cardiotonic effect Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 231100000895 deafness Toxicity 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000006735 deficit Effects 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 208000016354 hearing loss disease Diseases 0.000 description 3
- 210000003026 hypopharynx Anatomy 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000002147 killing effect Effects 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 230000000242 pagocytic effect Effects 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 235000019615 sensations Nutrition 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 230000004206 stomach function Effects 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- 210000004291 uterus Anatomy 0.000 description 3
- 230000037314 wound repair Effects 0.000 description 3
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- 206010050013 Abulia Diseases 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 206010002942 Apathy Diseases 0.000 description 2
- 206010002953 Aphonia Diseases 0.000 description 2
- 206010003591 Ataxia Diseases 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 206010010356 Congenital anomaly Diseases 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- 206010010947 Coordination abnormal Diseases 0.000 description 2
- 206010012289 Dementia Diseases 0.000 description 2
- 206010012374 Depressed mood Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 208000010228 Erectile Dysfunction Diseases 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 208000036119 Frailty Diseases 0.000 description 2
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 238000012449 Kunming mouse Methods 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 206010025421 Macule Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000007443 Neurasthenia Diseases 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- FYRHTIWFKXZWAD-UHFFFAOYSA-N Sarisan Chemical compound C1=C(CC=C)C(OC)=CC2=C1OCO2 FYRHTIWFKXZWAD-UHFFFAOYSA-N 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 206010039897 Sedation Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 208000024780 Urticaria Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- 208000031975 Yang Deficiency Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 231100000460 acute oral toxicity Toxicity 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000001773 anti-convulsant effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 230000010100 anticoagulation Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 206010008118 cerebral infarction Diseases 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 208000035850 clinical syndrome Diseases 0.000 description 2
- 208000010877 cognitive disease Diseases 0.000 description 2
- 230000003920 cognitive function Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 208000028659 discharge Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 208000017574 dry cough Diseases 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 230000000147 hypnotic effect Effects 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 230000007954 hypoxia Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 208000016290 incoordination Diseases 0.000 description 2
- 208000021267 infertility disease Diseases 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 239000008518 lycium barbarum polysaccharide Substances 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 230000001932 seasonal effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000036280 sedation Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 231100000022 skin irritation / corrosion Toxicity 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 208000023409 throat pain Diseases 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000820 toxicity test Toxicity 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 239000008675 zhuhuang Substances 0.000 description 2
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- PMXMIIMHBWHSKN-UHFFFAOYSA-N 3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one Chemical compound FC1=CC=C2C(C3CCN(CC3)CCC=3C(=O)N4CCCC(O)C4=NC=3C)=NOC2=C1 PMXMIIMHBWHSKN-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000117 Abnormal behaviour Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 208000017194 Affective disease Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 235000010894 Artemisia argyi Nutrition 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 241000003910 Baronia <angiosperm> Species 0.000 description 1
- 208000003014 Bites and Stings Diseases 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 208000019300 CLIPPERS Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000013017 Child Nutrition disease Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 241001550206 Colla Species 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 206010012241 Delusion of grandeur Diseases 0.000 description 1
- 206010051244 Dyschezia Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 241000221079 Euphorbia <genus> Species 0.000 description 1
- 206010016029 Face oedema Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010067715 Gastrointestinal sounds abnormal Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 208000018779 Globus Sensation Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019072 Hallucination, olfactory Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010049976 Impatience Diseases 0.000 description 1
- 206010021531 Impetigo Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241000699684 Meriones unguiculatus Species 0.000 description 1
- 241000361919 Metaphire sieboldi Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000019022 Mood disease Diseases 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 241000699667 Mus spretus Species 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 206010028916 Neologism Diseases 0.000 description 1
- 208000027626 Neurocognitive disease Diseases 0.000 description 1
- 206010029412 Nightmare Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241001092500 Photinia x fraseri Species 0.000 description 1
- 241000596297 Photis Species 0.000 description 1
- 206010035148 Plague Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 208000037062 Polyps Diseases 0.000 description 1
- 208000037048 Prodromal Symptoms Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- 241000167686 Reichardia Species 0.000 description 1
- 206010062104 Renal mass Diseases 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000131808 Scolopendra Species 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- 206010061363 Skeletal injury Diseases 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 208000003217 Tetany Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 244000044283 Toxicodendron succedaneum Species 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000016571 aggressive behavior Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 201000009961 allergic asthma Diseases 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000000433 anti-nutritional effect Effects 0.000 description 1
- 230000002225 anti-radical effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 244000030166 artemisia Species 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 201000009361 ascariasis Diseases 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 1
- 229910001626 barium chloride Inorganic materials 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000003181 biological factor Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 201000007295 breast benign neoplasm Diseases 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 235000019994 cava Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000021930 chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- QZUDBNBUXVUHMW-UHFFFAOYSA-N clozapine Chemical compound C1CN(C)CCN1C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12 QZUDBNBUXVUHMW-UHFFFAOYSA-N 0.000 description 1
- 229940068796 clozaril Drugs 0.000 description 1
- 229960001338 colchicine Drugs 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- -1 does not forge Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000007937 eating Effects 0.000 description 1
- 230000006397 emotional response Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 238000005242 forging Methods 0.000 description 1
- 239000010135 fructus aurantii immaturus Substances 0.000 description 1
- 238000003958 fumigation Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000000025 haemostatic effect Effects 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000011337 individualized treatment Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000010365 information processing Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 210000001767 medulla oblongata Anatomy 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 208000010553 multiple abscesses Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000002981 neuropathic effect Effects 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 238000007034 nitrosation reaction Methods 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000001734 parasympathetic effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000032361 posttranscriptional gene silencing Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 229940001470 psychoactive drug Drugs 0.000 description 1
- 239000004089 psychotropic agent Substances 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 208000010540 rapid respiration Diseases 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- RAPZEAPATHNIPO-UHFFFAOYSA-N risperidone Chemical compound FC1=CC=C2C(C3CCN(CC3)CCC=3C(=O)N4CCCCC4=NC=3C)=NOC2=C1 RAPZEAPATHNIPO-UHFFFAOYSA-N 0.000 description 1
- 229960001534 risperidone Drugs 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 230000010332 selective attention Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 230000006403 short-term memory Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 238000010911 splenectomy Methods 0.000 description 1
- 210000004988 splenocyte Anatomy 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229930002534 steroid glycoside Natural products 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 210000005182 tip of the tongue Anatomy 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 201000006382 tuberculoid leprosy Diseases 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000001755 vocal effect Effects 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 230000003936 working memory Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Group | Number of cases | Recovery from illness | Effective | Effectively | Invalid | Recovery from illness and obvious effective rate | Effective percentage |
Treatment group 1 | 42 | 13 | 14 | 10 | 5 | (27) 64.3% | 88.1% |
Treatment group 2 | 42 | 14 | 15 | 10 | 3 | (29) 69.0% | 92.9% |
Treatment group 3 | 42 | 16 | 17 | 8 | 1 | (33) 78.6% | 97.6% |
Matched group | 42 | 5 | 9 | 15 | 13 | (14) 33.3% | 69.0% |
Group | Number of cases | The 2-3 course for the treatment of | The 4-5 course for the treatment of | 6th course for the treatment of |
Treatment group 1 | 27 | 8(29.6%) | 11(40.7%) | 8(29.6%) |
Treatment group 2 | 29 | 9(31.0%) | 12(41.4%) | 8(27.6%) |
Treatment group 3 | 33 | 11(33.3%) | 15(45.6%) | 7(21.2%) |
Matched group | 14 | 3(21.4%) | 5(35.7%) | 6(42.9%) |
Claims (6)
- null1. it is used for treating the heart schizoid medicine of kidney disorder type,It is characterized in that,Described medicine includes endo-medicine and external used medicine,Described endo-medicine is made up of the raw medicinal material of following parts by weight: Mirabilitum crystallina 5-9 weight portion、Fructus Gardeniae 10-15 weight portion、Folium Bambusae 10-20 weight portion、Rhizoma Coptidis 15-25 weight portion、Rhizoma Bistortae 10-15 weight portion、Radix Rehmanniae 5-15 weight portion、Radix Scrophulariae 10-15 weight portion、Cornu Bubali 3-9 weight portion、Lapis Micae Aureus 3-10 weight portion、Pheretima 10-15 weight portion、Radix Polygoni Multiflori Preparata 10-20 weight portion、Flos Rosae Rugosae 15-25 weight portion、FLOS MUME 10-15 weight portion、Nidus Vespae 10-25 weight portion、Radix Ranunculi Ternati 5-10 weight portion、Bombyx Batryticatus 15-25 weight portion、Succus Bambusae 10-15 weight portion、Concretio Silicea Bambusae 5-15 weight portion、Radix Platycodonis 10-20 weight portion、Bulbus Lilii 15-25 weight portion、Radix Asparagi 10-20 weight portion、Rhizoma Polygonati Odorati 5-15 weight portion、Rhizoma Polygonati 10-15 weight portion、Fructus Lycii 15-25 weight portion、Fructus Ligustri Lucidi 10-17 weight portion、Fructus Mori 15-25 weight portion、Carapax Et Plastrum Testudinis 3-8 weight portion、Folium Artemisiae Argyi 10-15 weight portion、Radix Trichosanthis 5-10 weight portion、Semen Ziziphi Spinosae 10-25 weight portion、Semen Platycladi 15-25 weight portion、Rhizoma et radix valerianae 9-16 weight portion、Radix Polygalae 10-15 weight portion and Rhizoma Acori Graminei 5-12 weight portion;Described external used medicine is made up of the raw medicinal material of following parts by weight: Radix Angelicae Sinensis 10-20 weight portion, Pericarpium Zanthoxyli 5-10 weight portion, Radix Polygalae 5-12 weight portion, Cortex Cinnamomi 5-8 weight portion, Amylum Nelumbinis Rhizomatis 5-20 weight portion, Rhizoma Atractylodis Macrocephalae 5-9 weight portion, Aloe 10-20 weight portion and Radix Aucklandiae 5-12 weight portion.
- null2. according to claim 1 for treating the heart schizoid medicine of kidney disorder type,It is characterized in that,In described endo-medicine, the parts by weight of each raw medicinal material are: Mirabilitum crystallina 7 weight portion、Fructus Gardeniae 12 weight portion、Folium Bambusae 15 weight portion、Rhizoma Coptidis 21 weight portion、Rhizoma Bistortae 12 weight portion、The Radix Rehmanniae 7 weight portion、Radix Scrophulariae 12 weight portion、Cornu Bubali 5 weight portion、Lapis Micae Aureus 7 weight portion、Pheretima 12 weight portion、Radix Polygoni Multiflori Preparata 15 weight portion、Flos Rosae Rugosae 22 weight portion、FLOS MUME 12 weight portion、Nidus Vespae 17 weight portion、Radix Ranunculi Ternati 7 weight portion、Bombyx Batryticatus 19 weight portion、Succus Bambusae 12 weight portion、Concretio Silicea Bambusae 11 weight portion、Radix Platycodonis 15 weight portion、Bulbus Lilii 21 weight portion、Radix Asparagi 15 weight portion、Rhizoma Polygonati Odorati 11 weight portion、Rhizoma Polygonati 12 weight portion、Fructus Lycii 21 weight portion、Fructus Ligustri Lucidi 14 weight portion、Fructus Mori 21 weight portion、Carapax Et Plastrum Testudinis 6 weight portion、Folium Artemisiae Argyi 13 weight portion、Radix Trichosanthis 6 weight portion、Semen Ziziphi Spinosae 22 weight portion、Semen Platycladi 21 weight portion、Rhizoma et radix valerianae 12 weight portion、Radix Polygalae 12 weight portion and Rhizoma Acori Graminei 7 weight portion;In described external used medicine, the parts by weight of each raw medicinal material are: Radix Angelicae Sinensis 15 weight portion, Pericarpium Zanthoxyli 7 weight portion, Radix Polygalae 8 weight portion, Cortex Cinnamomi 6 weight portion, Amylum Nelumbinis Rhizomatis 12 weight portion, the Rhizoma Atractylodis Macrocephalae 7 weight portion, Aloe 15 weight portion and the Radix Aucklandiae 7 weight portion.
- null3. according to claim 1 for treating the heart schizoid medicine of kidney disorder type,It is characterized in that,In described endo-medicine, the parts by weight of each raw medicinal material are: Mirabilitum crystallina 5 weight portion、Fructus Gardeniae 15 weight portion、Folium Bambusae 20 weight portion、Rhizoma Coptidis 25 weight portion、Rhizoma Bistortae 10 weight portion、The Radix Rehmanniae 5 weight portion、Radix Scrophulariae 10 weight portion、Cornu Bubali 3 weight portion、Lapis Micae Aureus 10 weight portion、Pheretima 10 weight portion、Radix Polygoni Multiflori Preparata 10 weight portion、Flos Rosae Rugosae 25 weight portion、FLOS MUME 15 weight portion、Nidus Vespae 25 weight portion、Radix Ranunculi Ternati 5 weight portion、Bombyx Batryticatus 25 weight portion、Succus Bambusae 10 weight portion、Concretio Silicea Bambusae 5 weight portion、Radix Platycodonis 10 weight portion、Bulbus Lilii 25 weight portion、Radix Asparagi 10 weight portion、Rhizoma Polygonati Odorati 15 weight portion、Rhizoma Polygonati 10 weight portion、Fructus Lycii 15 weight portion、Fructus Ligustri Lucidi 10 weight portion、Fructus Mori 15 weight portion、Carapax Et Plastrum Testudinis 3 weight portion、Folium Artemisiae Argyi 15 weight portion、Radix Trichosanthis 10 weight portion、Semen Ziziphi Spinosae 25 weight portion、Semen Platycladi 25 weight portion、Rhizoma et radix valerianae 16 weight portion、Radix Polygalae 10 weight portion and Rhizoma Acori Graminei 5 weight portion;In described medicine for external use thing, the parts by weight of each raw medicinal material are: Radix Angelicae Sinensis 20 weight portion, Pericarpium Zanthoxyli 10 weight portion, Radix Polygalae 5 weight portion, Cortex Cinnamomi 8 weight portion, Amylum Nelumbinis Rhizomatis 15 weight portion, the Rhizoma Atractylodis Macrocephalae 9 weight portion, Aloe 20 weight portion and the Radix Aucklandiae 12 weight portion.
- 4. the preparation method for treating the heart schizoid medicine of kidney disorder type according to any one of claim 1-3, it is characterised in that the dosage form of described endo-medicine is oral solutions, and its preparation method comprises the following steps:The first step, Fructus Gardeniae, Folium Bambusae, Pheretima, Radix Polygoni Multiflori Preparata and Flos Rosae Rugosae are mixed, adding relative to mixture 3 times~5 times amount determining alcohol is the ethanol of 55%~65%, reflux, extract, 2~4 times, each 2 hours~3 hours, filters, filtrate merges, reclaiming ethanol, being concentrated into 70 DEG C of relative densities is the mastic of 1.30~1.32, standby;Second step, is mixed in proportion surplus stock medical material, adds relative to mixture 3~5 times amount water, boils 2~4 hours, filters, and being concentrated into 70 DEG C of relative densities is the mastic of 1.27~1.29;3rd step, the described mastic mixing first step, second step obtained, 55 DEG C~65 DEG C reduced vacuum dry, and get dry extract powder;4th step, added ethanol in the described dried cream powder the 3rd step obtained, obtains containing alcohol mastic, and the alcohol content of described containing alcohol mastic is 65%~70%;Described containing alcohol mastic being sequentially carried out chilling treatment, precipitation process, filtration treatment, recovery Ethanol Treatment, obtains dealcoholysis mastic, wherein, the chilling treatment time is 30~40 hours;5th step, will add cane sugar powder, activated carbon in described dealcoholysis mastic, be sequentially carried out heat treated, filtration treatment, dilution process, obtain semi-finished product;The weight ratio of described dealcoholysis mastic and described cane sugar powder is 1: 0.1~0.3;The weight ratio of described dealcoholysis mastic and described activated carbon is 1: 0.001~0.002;The time of described heat treated is 20~40 minutes, and temperature is 100 DEG C~110 DEG C;6th step, the more described semi-finished product that the 5th step obtains are sequentially carried out filtration treatment, embedding process, sterilization treatment, obtain described Chinese medicine preparation oral liquid finished product.
- 5. the preparation method for treating the heart schizoid medicine of kidney disorder type according to any one of claim 1-3, it is characterised in that the dosage form of described endo-medicine is tablet, and its preparation method comprises the following steps:The first step, is mixed in proportion described each raw medicinal material, adds the ethanol that determining alcohol is 85%~95% relative to mixture quality 2~4 times, is heated to reflux 1~3 hour, extracts, and filters and obtains the first extracting solution;Filter the medicinal residues obtained and add the ethanol that determining alcohol is 85%~95% relative to described medicinal residues quality 1~2 times, be heated to reflux 1~3 hour, extract, filter and obtain the second extracting solution;First extracting solution and the second extracting solution being merged, concentrating under reduced pressure removes alcohol solvent, dry, it is thus achieved that dry cream;Second step, is placed in super micron mill by the dry cream that the first step obtains and pulverizes 1~2 hour, pulverizes, sieves, it is thus achieved that the micropowders of 300 order~400 orders;3rd step, the micropowders that second step is obtained, add relative to the microcrystalline Cellulose of its quality 0.1~0.3 times, 0.05~0.15 times of lactose, the starch of 0.1~0.3 times, sieve, mix homogeneously, granulate, dry, add relative to 0.005~0.05 times of magnesium stearate of micropowders quality, granulate, tabletting, makes.
- 6. the preparation method for treating the heart schizoid medicine of kidney disorder type according to any one of claim 1-3, it is characterised in that the dosage form of described external used medicine is navel patch, and its preparation method comprises the following steps:The first step, is mixed in proportion described each raw medicinal material, is ground into the powder of 40 order~60 orders, adds the ethanol that determining alcohol is 85~95% relative to mixture quality 2~4 times, is heated to reflux 1~3 hour, extracts, and filters and obtains the first extracting solution;Filter the medicinal residues obtained and add the ethanol that determining alcohol is 85~95% relative to described medicinal residues quality 1~2 times, be heated to reflux 1~3 hour, extract, filter and obtain the second extracting solution;First extracting solution and the second extracting solution being merged, concentrating under reduced pressure removes alcohol solvent, dry, it is thus achieved that dry cream, is ground into the powder of 100 order~200 orders;Second step, dissolves stearic acid heating, and being maintained at temperature is 70 DEG C~80 DEG C, it is thus achieved that stearic acid liquid;It addition, potassium hydroxide, glycerol, ethyl hydroxybenzoate and distilled water to be pressed the part by weight mixing of 5:500:1:600, heating, maintain the temperature at 70 DEG C~80 DEG C, it is thus achieved that distilled water mixed liquor;Stearic acid liquid is slowly added in distilled water mixed liquor according to the part by weight of 1:100, stirs cooling, it is thus achieved that substrate simultaneously;3rd step, the substrate obtained to second step adds the Chinese medicinal powder that the first step of equivalent obtains, and is constantly ground to uniformly, and heating obtains sticky paste, granulates, and after drying, obtains pill, coordinates medical proof fabric or special navel paster that pill is attached to umbilicus place.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410258697.2A CN104001057B (en) | 2014-06-12 | 2014-06-12 | For treating the heart schizoid medicine of kidney disorder type and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410258697.2A CN104001057B (en) | 2014-06-12 | 2014-06-12 | For treating the heart schizoid medicine of kidney disorder type and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104001057A CN104001057A (en) | 2014-08-27 |
CN104001057B true CN104001057B (en) | 2016-07-13 |
Family
ID=51362145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410258697.2A Expired - Fee Related CN104001057B (en) | 2014-06-12 | 2014-06-12 | For treating the heart schizoid medicine of kidney disorder type and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104001057B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105561083A (en) * | 2016-01-13 | 2016-05-11 | 济南思拓新源医药科技有限公司 | Medicine composition for treating blood stasis heating type postpartum fever and preparation method thereof |
CN105535751A (en) * | 2016-01-15 | 2016-05-04 | 夏承生 | Traditional Chinese medicine for treating postdural puncture headache and preparation method thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101816756B (en) * | 2010-06-02 | 2012-05-23 | 泰一和浦(北京)中医药研究院有限公司 | Chinese medicinal composition for treating upset and irritability and preparation method thereof |
CN101816771B (en) * | 2010-06-02 | 2011-12-28 | 泰一和浦(北京)中医药研究院有限公司 | Chinese medicinal composition for treating epilepsy disease and preparation method thereof |
CN102886013A (en) * | 2012-10-26 | 2013-01-23 | 王澜舸 | Shiniu antipyretic oral liquid |
-
2014
- 2014-06-12 CN CN201410258697.2A patent/CN104001057B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN104001057A (en) | 2014-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103432475B (en) | Traditional Chinese medicine composition for treating allergic rhinitis and preparation method thereof | |
CN103768567B (en) | A kind of black plaster and preparation method thereof | |
CN104398934A (en) | Traditional Chinese medicine combination for treating cutaneous pruritus and preparation method thereof | |
CN103860941A (en) | Traditional Chinese medicine for treating schizophrenia and preparation method thereof | |
CN103638250B (en) | One treats prosopoplegic Chinese medicine preparation and preparation method thereof | |
CN104940727A (en) | Paste for treating rhinitis and preparation method thereof | |
CN102178877B (en) | External preparation for treating eczema of scrotum and preparation method thereof | |
CN104857288B (en) | Treat the Chinese medicine preparation and preparation method thereof of white hair | |
CN104127813A (en) | Traditional Chinese medicinal composition for curing qi-blood deficiency type bedsore and preparation method thereof | |
CN102908474B (en) | Medicinal liquor for treating neurosis | |
CN104001057B (en) | For treating the heart schizoid medicine of kidney disorder type and preparation method thereof | |
CN104524464A (en) | Traditional Chinese medicine preparation for treating hyperactivity and preparation method of traditional Chinese medicine preparation | |
CN104524462A (en) | Traditional Chinese medicine formula for treating craniocerebral injury or intracranial tumour postoperative vertigo | |
CN107875256B (en) | Zhuang-medicine acupoint application plaster for treating insomnia and manufacturing method thereof | |
CN103920042A (en) | Drug for treating heat invasion nutritive blood type virus meningitis, as well as preparation method thereof | |
CN104013950A (en) | Traditional Chinese medicine composition for treating toxin and decay type bedsore and preparation method of composition | |
CN103961578A (en) | Traditional Chinese medicine medicinal liquor for treating neurasthenia | |
CN104940710B (en) | Healthy and free from worry Chinese medicine composition of tabasheer epilepsy and preparation method thereof | |
CN103705680A (en) | Traditional Chinese medicine composition for treating rhinitis and preparation method thereof | |
CN103479968A (en) | Traditional Chinese medicine composition for treating heart-fire flaming acne | |
CN116350704B (en) | Traditional Chinese medicine composition for treating secondary epilepsy and preparation method thereof | |
CN106924578A (en) | A kind of Chinese medicine for treating carbuncle furuncle poison | |
CN106177736A (en) | A kind of alleviate gastrointestinal upset Chinese mugwort leaf health care tea causing constipation and preparation method thereof | |
CN105770773A (en) | Traditional Chinese medicinal preparation for treating adult mild brain disturbance and preparation method of traditional Chinese medicinal preparation | |
CN105194442A (en) | Traditional Chinese medicine composition for treating neurasthenia and preparation method of composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Liu Guangyi Inventor after: Cao Yongxian Inventor after: Zhang Nana Inventor before: Liu Guangyi |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LIU GUANGYI TO: LIU GUANGYI CAO YONGXIAN ZHANG NANA |
|
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Hui Inventor after: Liu Guangyi Inventor after: Zhang Di Inventor after: Cao Yongxian Inventor after: Zhang Nana Inventor after: Liu Bing Inventor before: Liu Guangyi Inventor before: Cao Yongxian Inventor before: Zhang Nana |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160422 Address after: 266003 Jiangsu Road, Shandong, China, No. 16, No. Applicant after: Affiliated Hospital of University Of Qingdao Applicant after: Qiingdao University hospital Address before: 266003 Jiangsu Road, Shandong, China, No. 16, No. Applicant before: Affiliated Hospital of University Of Qingdao |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160713 Termination date: 20170612 |
|
CF01 | Termination of patent right due to non-payment of annual fee |